We report here the introduction of SARS-COV-2 C.37, a variant of interest (VOI) recently renamed "lambda" by WHO, from Peru to Italy. We discuss mutations of concern in this lineage, and evidences for impaired sensitivity to neutralizing antibody-therapeutics and vaccines. This article is protected by copyright. All rights reserved.

Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy

Baj, Andreina
Primo
;
Novazzi, Federica
Secondo
;
Genoni, Angelo;Tamborini, Antonio;Maggi, Fabrizio
Ultimo
2021-01-01

Abstract

We report here the introduction of SARS-COV-2 C.37, a variant of interest (VOI) recently renamed "lambda" by WHO, from Peru to Italy. We discuss mutations of concern in this lineage, and evidences for impaired sensitivity to neutralizing antibody-therapeutics and vaccines. This article is protected by copyright. All rights reserved.
2021
20D; COVID-19; GR/452Q.V1; Lambda variant; SARS-COV-2 C.37; SARS-CoV-2; variant of interest
Baj, Andreina; Novazzi, Federica; Ferrante, Francesca Drago; Genoni, Angelo; Cassani, Gianluca; Prestia, Martina; Colombo, Alberto; Capuano, Riccardo; Zago, Christian; Pasciuta, Renee; Tamborini, Antonio; Rossi, Agostino; Tettamanzi, Elena; Catanoso, Giuseppe; Focosi, Daniele; Maffioli, Lorenzo; Maggi, Fabrizio
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2114564
 Attenzione

L'Ateneo sottopone a validazione solo i file PDF allegati

Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact